Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -26.45% is 48% above its 5-year average of -51.16%, around the middle of its 5-year range (-80.35%–-1.26%).
54.88% above its 12-month average of -58.62%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -2.51%.
RETURN ON ASSETS (ROA)
-26.45%
RETURN ON ASSETS (ROA) AVG TTM
-58.62%
RETURN ON ASSETS (ROA) AVG 3Y
-47.64%
RETURN ON ASSETS (ROA) AVG 5Y
-51.16%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+54.88%
CURRENT VS 3Y AVG
+44.48%
CURRENT VS 5Y AVG
+48.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
+13.84%
vs the sector median at left
Biofrontera Inc.
Market Cap
$11.52M
Return on Assets (ROA)
-26.45%
TTM Avg
-58.62%
3Y Avg
-47.64%
5Y Avg
-51.16%
Market Cap
$11.54M
Return on Assets (ROA)
-98.26%
TTM Avg
-77.06%
3Y Avg
-65.68%
5Y Avg
-62.77%
Market Cap
$11.44M
Return on Assets (ROA)
-90.19%
TTM Avg
-82.55%
3Y Avg
-92.57%
5Y Avg
-79.83%
Market Cap
$11.69M
Return on Assets (ROA)
-198.70%
TTM Avg
-189.50%
3Y Avg
-187.22%
5Y Avg
-200.18%
Market Cap
$11.30M
Return on Assets (ROA)
-46.21%
TTM Avg
-17.41%
3Y Avg
-49.70%
5Y Avg
-52.01%
Market Cap
$11.62M
Return on Assets (ROA)
-77.94%
TTM Avg
-178.68%
3Y Avg
-1009.31%
5Y Avg
-2782.57%
Market Cap
$11.08M
Return on Assets (ROA)
-154.89%
TTM Avg
-40.68%
3Y Avg
-87.98%
5Y Avg
-439.28%
Market Cap
$11.36M
Return on Assets (ROA)
-185.94%
TTM Avg
-166.39%
3Y Avg
-133.67%
5Y Avg
-110.62%
Market Cap
$10.84M
Return on Assets (ROA)
-132.59%
TTM Avg
-75.28%
3Y Avg
-65.73%
5Y Avg
-52.31%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biofrontera Inc. (BFRI) | $11.52M | -26.45% | -58.62% | -47.64% | -51.16% |
| Pluri Inc. (PLUR)vs › | $11.54M | -98.26% | -77.06% | -65.68% | -62.77% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.44M | -90.19% | -82.55% | -92.57% | -79.83% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.69M | -198.70% | -189.50% | -187.22% | -200.18% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | -46.21% | -17.41% | -49.70% | -52.01% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.62M | -77.94% | -178.68% | -1009.31% | -2782.57% |
| BioVie Inc. (BIVI)vs › | $11.08M | -154.89% | -40.68% | -87.98% | -439.28% |
| Cerenome, Inc. (CNSY)vs › | $11.36M | -185.94% | -166.39% | -133.67% | -110.62% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.84M | -132.59% | -75.28% | -65.73% | -52.31% |
| Lifeward Ltd. (LFWD)vs › | $10.57M | -88.09% | -90.94% | -60.82% | -50.49% |
ROA
-26.4%
ROE
-106.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -36.89% |
| 2024-12-31 | -80.35% |
| 2023-12-31 | -72.07% |
| 2022-12-31 | -1.26% |
| 2021-12-31 | -70.86% |
| 2020-12-31 | -45.52% |
| 2019-12-31 | -38.20% |
